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Abstract The Serratia nuclease is a non-specific endonuclease
which cleaves single- and double-stranded RNA and DNA. It is a
member of a large family of related endonucleases, most of which
are dimers of identical subunits, with the notable exception of the
Anabaena nuclease which is a monomer. In order to find out
whether the dimer state of the Serratia nuclease is essential for
its function we have produced variants of this nuclease which
based on the crystal structure (Miller, M.D. and Krause, K.L.
(1996), Protein Science 5, 24^33) were expected to be unable to
dimerise. We demonstrate here that these variants, H184A,
H184N, H184T and H184R, are monomers and have the same
secondary structure, stability towards chemical denaturation and
activity as the wild-type enzyme. This allows to conclude that the
dimeric state is not essential for the catalytic function of the
Serratia nuclease. In contrast, the S179C variant which is also a
monomer shows little activity, presumably because this amino
acid substitution changes the structure of the enzyme.
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1. Introduction
The extracellular Serratia marcescens nuclease is a non-spe-
ci¢c endonuclease, capable of cleaving single- and double-
stranded RNA and DNA with very high speci¢c activity [2^
6]. Like many other non-speci¢c nucleases, it exhibits certain
sequence preferences [3,6,7], suggesting that local structural
features of the substrate in£uence the rate of cleavage. It
requires Mg2 for phosphodiester bond cleavage and produ-
ces 5P-phosphorylated oligonucleotides [8^10]. Mutational
analyses which were based on the crystal structure [11] and
a comparison with the amino acid sequence of several related
enzymes [12^14] have allowed to identify amino acid residues
essential for catalysis and to suggest a mechanism of action
for this enzyme [15,16] which was corroborated by kinetic
analyses using various natural and chemically modi¢ed sub-
strates [5,17].
The Serratia nuclease is a member of a family of non-spe-
ci¢c nucleases found in both prokaryotic and eukaryotic or-
ganisms, some of which have been characterised in detail : in
addition to the Serratia nuclease, NucA from Anabaena sp.
[13,18,19], Nuc1 from Saccharomyces cerevisiae [12,20], endo-
nuclease G from Bos taurus [14,21], and a RNA/DNA non-
speci¢c nuclease from the mold Syncephalostrum racemosum
[22]. Others have been identi¢ed on the basis of their sequence
homology to the Serratia nuclease, for example a homologous
nuclease from Borrelia burgdorferi whose sequence was ob-
tained in a genome sequencing project [23].
While the Serratia nuclease [24,25,1], Nuc1 [12] and endo-
nuclease G [26] were reported to be homodimers, NucA is a
monomer [19], raising the question whether the dimeric state
of the Serratia nuclease, Nuc1 and endonuclease G is essential
for the activity of these enzymes and/or whether these en-
zymes have to dissociate into monomers for catalysis. This
is not only a question of academic interest but has a techno-
logical aspect to it, as the Serratia nuclease (Benzonase) is an
enzyme of commercial importance, which is used to degrade
nucleic acids in biochemical and pharmaceutical preparations.
For this purpose e¡orts are being undertaken to immobilise
the enzyme on solid support. This would be much easier to
accomplish with an active monomeric variant.
Based on the detailed crystallographic analyses of the Ser-
ratia nuclease [1,27] which have clearly identi¢ed the physio-
logical dimer interface, we have designed variants of the Ser-
ratia nuclease which should not be able to dimerise. We report
here the genetic engineering, production and characterisation
of such variants. Our results demonstrate that the dimer state
of the Serratia nuclease is not necessary for the catalytic func-
tion of this enzyme, as monomeric variants with the same
speci¢c activity have been identi¢ed.
2. Materials and methods
2.1. In vitro mutagenesis and sequencing
In vitro mutagenesis to obtain the S179C, H184N, H184T and
H184R variants was carried out using the 2-PCR method [15,28].
The H184A variant was generated applying an inverse PCR strategy
[19,29]. The mutations were veri¢ed by sequencing using the ABI
PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit with
AmpliTaq DNA Polymerase FS, on an ABI 373A DNA sequencer
(Applied Biosystems) according to the supplier’s protocol.
2.2. Overexpression and puri¢cation of Serratia nuclease and variants
The wild-type Serratia nuclease and the variant enzymes S179C,
H184A, H184N, H184T and H184R were produced as His6GlySer-
tagged proteins in E. coli and puri¢ed as described before [25,5].
2.3. Gel ¢ltration analysis
Preparative and analytical gel ¢ltration experiments were carried
out at 25‡C on a Beckman Biosys 2000 HPLC system using a Merck
Superformance 600-16 Fractogel EMD BioSEC (S) and a Pharmacia
Superdex 75 HR 10/30 column. The protein concentration was 40 WM.
2.4. Analytical ultracentrifugation analysis
Analytical ultracentrifugation experiments were carried out at 20‡C
and 45 000 min31 in a Beckman Optima XL-A centrifuge equipped
with absorption optics and an An-50 8-place rotor. The protein con-
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